Perinatally acquired bacterial sepsis: Analysis of a new approach, are we on the right tract? 2nd part: Uncertainties and proposals;Infection bactérienne néonatale par contamination materno-fœtale: Pour un changement de paradigme? 2e partie: Incertitudes et propositions

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 30, Issue 6, 2001, Pages 533-551

  Blond, M H ^a   Gold, F ^a   Pierre, F ^a   Quentin, R ^a   Aujard, Y ^a  

^a Centre de Pediatrie Clocheville   (France)

Author keywords

Antenatal screening; Group B streptococci; Neonatal sepsis; Perinatal infections; Prophylactic antibiotics in obstetrics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFOTAXIME; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; NEWBORN INFECTION; PERINATAL INFECTION; PRACTICE GUIDELINE; PREMATURITY; PRENATAL DIAGNOSIS; PREVALENCE; REVIEW; RISK FACTOR; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DISEASE TRANSMISSION, VERTICAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HAEMOPHILUS INFECTIONS; HUMANS; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PREGNANCY; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0034772429     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
2. Risk factors for early-onset group B streptococcal sepsis: Estimation of odds ratios by critical literature review
3. Mortality from early onset group B streptococcal infection in the United Kingdom
4. Preventing early-onset group B streptococcal sepsis: Strategy development using decision analysis
5. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
6. Prevention of perinatal group B streptococcal infection: Adressing current controversies
7. Early-onset group B streptococcal disease - United States, 1998-1999
8. Decreasing incidence of perinatal group B streptococcal disease - United States, 1993-1995
9. Opportunities for prevention of perinatal group B streptococcal disease: A multistate surveillance analysis
10. Épidémiologie bactérienne de l'infection materno-fœtale: Expérience d'un centre périnatal
11. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III
12. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis
13. Prevention of early-onset neonatal group B streptococcal disease
14. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development
15. Prevention of perinatal group B streptococcal disease: A Public Health perspective
16. Colonization with group B streptococci in pregnancy and adverse outcome
17. Revised guidelines for prevention of early-onset group B Streptococcal (GBS) infection
18. Déclenchement: Facteurs de risque de contamination materno-fœtale à l'acouchement?
19. Selective intrapartum prophylaxis for group B streptococcus colonization: Management and outcome of newborns
20. Infection bactérienne du nouveau-né par contamination materno-fœtale: On peut se fier à l'anamnèse
21. Infection bactérienne du nouveau-né par contamination materno-fœtale: Étude épidémiologique rétrospective dans une maternité
22. Prevention of early onset group B streptococcal infection: Screen, treat, or observe?
23. Flore bactérienne génitale chez la femme enceinte
24. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study
25. Vaginal infection and preterm labour
26. Les infections du nouveau-né: Aspects fondamentaux, facteurs de virulence et physiopathologie
27. Neonatal escherichia coli infections: Concerns regarding resistance to current therapy
28. Infections materno-fœtales à Haemophilus Influenzae
29. Genetic characterization of a cryptic genospecies of Haemophilus causing urogenital and neonatal infections
30. Pneumococcal infection in the newborn
31. Intrapartum transmission of group A streptococcus
32. Comparison of prevention strategies for neonatal group B streptococcal infections: A population-based economic analysis
33. Peripartum infection associated with vaginal group B streptococcal colonization
34. Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis
35. Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis
36. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains
37. Genotyping may provide rapid identification of Escherichia coli K1 organisms that cause neonatal meningitis
38. Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis
39. Group B streptococci: Results of a protocol of antepartum screening and intrapartum treatment
40. Les défenses anti-infectieuses. L'infection bactérienne néonatale
41. Developmental immunobiology
42. Développement et maturation des moyens de défense antibactérienne
43. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women
44. Universal screening for group B streptococcus: Recommandations and obstetricians' practice decisions
45. Group B Streptococcus: Perinatal considerations
46. Hospital-based policies for prevention of perinatal group B Streptococcal disease - United States, 1999
47. Antimicrobial prevention of early-onset group B Streptococcal sepsis: Estimates of risk reduction based on a critical literature review
48. Management of neonates born to mothers with group B streptoccocus colonization
49. Conduite à tenir face à une colonisation materno-infantile à streptocoques du groupe B
50. Prenatal screening for group B streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care
51. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care
52. Single-dose penicillin prophylaxis against neonatal group B streptococcal infections
53. Prevention of early-onset group B streptococcal disease with selective intrapartum chemoprophylaxis
54. Multistate case-control study of maternal risk factors for neonatal Group B streptococcal disease
55. Prélèvements vaginaux et endocervicaux: Quand et comment les réaliser?
56. Risk factors for neonatal sepsis
57. Infections du nouveau-né
58. Résultats d'une enquête nationale sur l'antibiothérapie de l'infection néonatale bactérienne par contamination materno-fœtale
59. Bacterial concentration and blood volume required for a positive blood culture
60. Volume of blood required to detect common neonatal pathogens
61. No lumbar puncture in the evaluation for early neonatal sepsis: Will meningitis be missed?
62. Méningites néonatales: Intérêt de la ponction lombaire systématique
63. Méningites bactériennes du nouveau-né: Aspects diagnostiques et thérapeutiques
64. Bactérial sepsis and meningitis
65. Neonatal Escherichia coli septicemia - Bacterial counts in blood
66. Infections néonatales
67. Marqueurs biologiques de l'infection materno-fœtale
68. Serial serum C-Reactive protein levels in the diagnosis of neonatal infection
69. Antibiothérapie en maternité: Importance d'une utilisation rationnelle
70. An antibiotic policy to prevent emergence of resistant bacilli
71. Antibiotics policies in neonatal intensive care units
72. L'élévation thermique au cours du travail
73. Diagnostic tests for bacterial infection from birth to 90 days - A systematic review
74. Netilmicin in the neonate: Population pharmacocinetic analysis and dosing recommendations
75. Les infections du nouveau-né: Aspect clinique et traitement
76. C-reactive protein is a useful marker for guiding duration of therapy in suspected neonatal bacterial infection
77. Infection bactérienne du nouveau-né par contamination materno-fœtale: Traitement antibiotique par voie orale du nouveau-né colonisé. Étude prospective dans une maternité
78. Concentration sériques d'amoxicilline après 4 doses orales de 25/mg/kg chez le nouveau-né
79. Broad-spectrum antibiotics for spontaneous preterm labour: The ORACLE II randomised trial
80. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: The ORACLE I randomised trial